» Articles » PMID: 28148249

What is the Association of Hypothyroidism with Risks of Cardiovascular Events and Mortality? A Meta-analysis of 55 Cohort Studies Involving 1,898,314 Participants

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2017 Feb 3
PMID 28148249
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whether hypothyroidism is an independent risk factor for cardiovascular events is still disputed. We aimed to assess the association between hypothyroidism and risks of cardiovascular events and mortality.

Methods: We searched PubMed and Embase from inception to 29 February 2016. Cohort studies were included with no restriction of hypothyroid states. Priori main outcomes were ischemic heart disease (IHD), cardiac mortality, cardiovascular mortality, and all-cause mortality.

Results: Fifty-five cohort studies involving 1,898,314 participants were identified. Patients with hypothyroidism, compared with euthyroidism, experienced higher risks of IHD (relative risk (RR): 1.13; 95% confidence interval (CI): 1.01-1.26), myocardial infarction (MI) (RR: 1.15; 95% CI: 1.05-1.25), cardiac mortality (RR: 1.96; 95% CI: 1.38-2.80), and all-cause mortality (RR: 1.25; 95% CI: 1.13-1.39); subclinical hypothyroidism (SCH; especially with thyrotropin level ≥10 mIU/L) was also associated with higher risks of IHD and cardiac mortality. Moreover, cardiac patients with hypothyroidism, compared with those with euthyroidism, experienced higher risks of cardiac mortality (RR: 2.22; 95% CI: 1.28-3.83) and all-cause mortality (RR: 1.51; 95% CI: 1.26-1.81).

Conclusions: Hypothyroidism is a risk factor for IHD and cardiac mortality. Hypothyroidism is associated with higher risks of cardiac mortality and all-cause mortality compared with euthyroidism in the general public or in patients with cardiac disease.

Citing Articles

Effect of thyroid stimulating hormone on the prognosis of coronary heart disease.

Ding N, Hua R, Guo H, Xu Y, Yuan Z, Wu Y Front Endocrinol (Lausanne). 2025; 16:1433106.

PMID: 40034227 PMC: 11872729. DOI: 10.3389/fendo.2025.1433106.


Thyroid and cardiovascular diseases.

Tan Oksuz S, Sahin M Turk J Med Sci. 2024; 54(7):1420-1427.

PMID: 39735488 PMC: 11673627. DOI: 10.55730/1300-0144.5927.


Phenome-wide association network demonstrates close connection with individual disease trajectories from the HUNT study.

Hall M, Skinderhaug M, Almaas E PLoS One. 2024; 19(12):e0311485.

PMID: 39729424 PMC: 11676826. DOI: 10.1371/journal.pone.0311485.


Beyond the Thyroid: A Narrative Review of Extra-thyroidal Manifestations in Hashimoto's Disease.

Kotak P, Kadam A, Acharya S, Kumar S, Varma A Cureus. 2024; 16(10):e71126.

PMID: 39525250 PMC: 11544504. DOI: 10.7759/cureus.71126.


Causal relationship between hypothyroidism and coronary atherosclerotic cardiovascular disease: a bidirectional two-sample Mendelian randomization.

Li J, Wang Y, Luo X, Meng T, Li C, Li J Front Cardiovasc Med. 2024; 11:1402359.

PMID: 39512367 PMC: 11540771. DOI: 10.3389/fcvm.2024.1402359.


References
1.
WOOLF B . On estimating the relation between blood group and disease. Ann Hum Genet. 1955; 19(4):251-3. DOI: 10.1111/j.1469-1809.1955.tb01348.x. View

2.
Grossman A, Weiss A, Koren-Morag N, Shimon I, Beloosesky Y, Meyerovitch J . Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study. Am J Med. 2015; 129(4):423-30. DOI: 10.1016/j.amjmed.2015.11.027. View

3.
Chaker L, Baumgartner C, den Elzen W, Ikram M, Blum M, Collet T . Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab. 2015; 100(6):2181-91. PMC: 4454799. DOI: 10.1210/jc.2015-1438. View

4.
Ochs N, Auer R, Bauer D, Nanchen D, Gussekloo J, Cornuz J . Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008; 148(11):832-45. DOI: 10.7326/0003-4819-148-11-200806030-00225. View

5.
Siristatidis C, Sergentanis T, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I . Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis. Hum Reprod Update. 2012; 19(2):105-23. DOI: 10.1093/humupd/dms051. View